Pyricontin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pyricontin

What is Pyricontin? Overview

Property Description
Active ingredient Pyridoxine Hydrochloride (Vitamin B6)
Form Oral Controlled-Release Tablet (CR)
Pharmacological class Vitamin (Water-Soluble B-Complex)
Common use Prevention and treatment of Vitamin B6 deficiency
Origin Synthetic compound

Pyricontin: Identity, Composition, and Classification

Pyricontin is a pharmaceutical product manufactured by Modi Mundi Pharma Pvt Ltd, fundamentally comprising Pyridoxine Hydrochloride, which is the stable, synthetic form of the essential nutrient known as Vitamin B6. This preparation is classified within the high-level pharmacological class of Vitamins, playing a role as a crucial coenzyme precursor in the body's metabolic machinery. The compound is utilized because it readily converts into pyridoxal 5'-phosphate, which is indispensable for countless enzymatic reactions essential for amino acid, carbohydrate, and fat metabolism. This formulation is clinically recognized for its application in managing conditions linked to inadequate intake of this vitamin.

Differentiating Features: The Controlled-Release Delivery System

A distinguishing feature of the Pyricontin line is its presentation as a controlled-release tablet (CR), which addresses the inherent challenge of supplementing water-soluble vitamins. This specialized oral dosage form is designed to gradually release the Pyridoxine Hydrochloride over an extended duration. This sustained release maintains a more consistent concentration of the essential nutrient in the bloodstream, optimizing the utilization and absorption of Vitamin B6 by the body's tissues. The primary, neutral use scenario for the single-ingredient product is to sustain health by correcting or preventing a nutritional deficiency that impacts nerve function and red blood cell formation.

Regulatory References

  1. Pyridoxine (Vitamin B6) Drug Information (MedlinePlus)
  2. Vitamin B6 (Pyridoxine) StatPearls (NCBI Bookshelf)

What side effects are possible with Pyricontin?

Possible Side Effects and Safety Information

The safety profile of Pyricontin (Pyridoxine Hydrochloride) is based on official government regulatory classifications, which primarily focus on the risks associated with the duration and amount of exposure.


Officially Documented Adverse Reactions

The most significant safety focus in regulatory documents relates to the Nervous System. The risk of adverse reactions is largely dependent on the dosage and duration of treatment, with most general undesirable effects often classified as Frequency Not Known by regulatory agencies due to insufficient data for estimation.

System-Organ Class Key Adverse Reaction Focus
Nervous System Disorders Sensory peripheral neuropathy (e.g., numbness, clumsiness)
Immune System Disorders Hypersensitivity reactions (allergic reactions)

Serious Adverse Reactions and Exposure Patterns

Official labeling documents that the most serious documented adverse reaction is Severe Sensory Peripheral Neuropathy. This condition is explicitly associated with the long-term administration of large daily doses of Pyridoxine (e.g., 200 mg or more per day) and is typically not observed when the medication is used at standard therapeutic doses for deficiency correction.

Safety-Related Restrictions and Specific Populations

Pyricontin is formally contraindicated in individuals with known hypersensitivity to the active substance or its components. Additionally, official safety notes address potential pharmacological interactions: Pyridoxine may reduce the therapeutic effect of Levodopa unless a dopa decarboxylase inhibitor is also co-administered. For Older Adults and during Pregnancy/Lactation, safety is maintained when the medication is used strictly at standard therapeutic doses to prevent or correct a deficiency, with caution against excessive intake.

Overdose and Emergency Response

Overdose and When to Seek Help

The overdose profile for Pyridoxine Hydrochloride (Pyricontin) is defined by the risk of chronic neurotoxicity associated with the prolonged administration of high doses, often exceeding 500 mg per day. Regulatory documentation states that this toxicity results in a sensory peripheral neuropathy, primarily affecting the nervous system.

Documented Overdose Manifestations

Type of Effect Official Regulatory Statement
Sensory Symptoms Paresthesias (tingling, burning), numbness, and loss of sensation
Motor Symptoms Ataxia (unsteady gait), muscle weakness, and clumsiness
Severe Outcome Risk of incomplete reversal or permanent sensory deficit from nerve damage

Official regulatory guidance mandates specific actions upon the manifestation of these signs. If a patient experiences persistent numbness, tingling, or difficulty walking/balancing, they must seek immediate medical advice and stop taking the supplemental Pyridoxine.

Overdose management is officially defined as symptomatic and supportive treatment, as regulatory agencies document that no specific antidote is known for Pyridoxine toxicity. The prompt cessation of intake is the required procedure to prevent the progression of nerve damage.

Therapeutic Uses of Pyricontin

What Pyricontin Treats: Main Uses and Benefits


The primary therapeutic role of Pyricontin (Pyridoxine HCl) is the prevention and management of clinical states resulting from Vitamin B6 deficiency. This medication is intended to address and prevent B6 deficiency arising from various causes, including dietary inadequacy, certain medications, and underlying medical conditions. It is applied across domains where additional symptomatic support is needed to address the consequences of this nutritional lack.

Commonly used across conditions presenting with deficiency-linked manifestations, Pyricontin is applied to help with groups of symptoms that may appear suddenly or fluctuate, including neurological, hematological, and skin manifestations.

“Pyricontin supports patients during difficult episodes by easing distress and may be part of symptomatic management in situations involving neurological risk.”

Quick Fact: Relief for Neurological Discomfort

The use of Pyricontin plays a role in managing sensory discomfort and may support cognitive stability when these issues are linked to a B6 imbalance, assisting with maintaining functional stability during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Pyricontin?

This section details the population eligibility and non-eligibility rules for Pyricontin (Pyridoxine Hydrochloride Controlled-Release) based strictly on official regulatory labeling.


Absolute Contraindication

Pyricontin is contraindicated in patients with a known hypersensitivity or allergy to the active ingredient, Pyridoxine, or to any other components of the formulation. This is the only absolute exclusion defined in the regulatory label.


Conditional and Restricted Use

Population Group Regulatory Status
Adults & Older Adults Established Use for the treatment and prevention of deficiency states.
Pediatric Population Not Recommended for deficiency states using this tablet presentation, due to lack of established data.
Hepatic or Renal Impairment Caution is Recommended due to the potential for reduced metabolism or metabolite accumulation.
Pregnancy & Lactation Permitted at therapeutic doses, as no adverse effects on the foetus or infant are generally documented. Caution is advised when prescribing.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Pyricontin (Pyridoxine HCl) as defined in government regulatory labeling.

Formally Contraindicated Combinations

Co-administration of Pyridoxine supplements is contraindicated in patients receiving Levodopa monotherapy because Pyridoxine formally antagonizes and reverses the therapeutic action of Levodopa. This restriction does not apply when Levodopa is combined with a dopa decarboxylase inhibitor such as Carbidopa. Regulatory documents also note a contraindication with MAO Inhibitors when Pyridoxine is present in certain combination products, due to a risk of intensified CNS effects.

Exposure-Altering Interactions

Several medicinal products are officially documented to substantially increase the body’s metabolic need for Pyridoxine, resulting in a drug-induced deficiency state. These substances include Isoniazid, Penicillamine, Hydralazine, and Cycloserine. The regulatory labels also specify that Oral Contraceptives may increase the required intake of Pyridoxine. Conversely, Pyridoxine may reduce the serum concentrations of some anticonvulsants, specifically Phenobarbital and Phenytoin.

Other Documented Interactions

  • Pharmacodynamic: Concurrent use with CNS depressants, including alcohol, is not recommended in combination products due to a documented risk of additive effects, such as severe drowsiness.
  • Substances: The consumption of large amounts of alcohol is officially documented to lower the levels of Vitamin B6 in the body.

Mechanism of Action

Pyricontin’s mechanism centers on supplying the precursor to the essential coenzyme Pyridoxal 5'-Phosphate (PLP), which is indispensable for countless enzymatic reactions. Its action is defined by enabling fundamental biochemical catalysis rather than directly blocking receptors or signaling pathways.

Enabling Coenzyme Function and Metabolic Catalysis

The drug's molecule is metabolically converted to PLP, which acts as a required cofactor for hundreds of apoenzymes, including vital transaminases and decarboxylases. This mechanism ensures the functionality of the machinery governing all amino acid metabolism and the precise transfer of functional groups across metabolic processes, contributing to the flow of protein components.

Modulation of Neurotransmitter and Heme Biosynthesis

The active PLP is a critical component for enzymes like Glutamic Acid Decarboxylase (GAD), which synthesizes the inhibitory neurotransmitter GABA, modulating neuronal signaling activity. Concurrently, it acts as a cofactor for delta-aminolevulinate synthase, the rate-limiting enzyme in heme synthesis. This dual-system support links the mechanism directly to the fundamental physiological processes of nervous system regulation and the production of hemoglobin and red blood cells .

Sustained Delivery for Optimized Bioactivation

The controlled-release formulation ensures a prolonged precursor supply. By maintaining a steady release of the precursor, the system supports a constant supply of the substrate necessary for continuous PLP bioactivation, thereby maintaining the functional coenzyme pool and sustained pathway engagement across its dependent pathways.

Dosage and Administration Information

How Pyricontin is Used: Official Administration Guidelines

Pyricontin is an Oral Controlled-Release Tablet of Pyridoxine Hydrochloride (Vitamin B6). The guidelines for its use are intended to standardize its administration and dosing in clinical practice.


Administration Scope

The Controlled-Release tablet is strictly for oral intake. To preserve the sustained-release mechanism, the tablet must be swallowed whole with water and must not be crushed, split, or chewed. The tablet may generally be taken **with or without food.


Standard Dosage and Schedule Principles

Feature Official Dosing Principle Regulatory Basis
Dosing Range Highly variable, dependent on deficiency severity. Regimens range from 2.5 to 10 mg daily for milder deficiency to 100 to 200 mg daily for initial intensive courses. Standard Clinical Practice
Frequency Pattern The Controlled-Release formulation is designed to support a once-daily intake for consistent therapeutic levels. Higher therapeutic doses may be administered in divided daily doses. Formulation Design
Course Duration Use involves an initial intensive course (e.g., 3 weeks) followed by a long-term daily maintenance regimen of a lower dose to prevent recurrence. Clinical Protocol
Age-Group Rules Dosage for children and adolescents is determined by individual need and age; requirements for older adults are generally similar to those of younger adults for deficiency treatment. Age-Based Standards

Procedural Administration Constraints

If a dose is missed, standard protocols involve skipping the missed dose and resuming the regular dosing schedule; a double dose should not be taken. This procedural structure ensures the medicine's steady-state concentration is maintained according to its pharmacokinetic design.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pyricontin


Evidence Overview for Vitamin B₆ Deficiency

Research on Pyricontin, which contains Pyridoxine Hydrochloride (Vitamin B₆), primarily focuses on its role as an essential nutrient and its use in addressing deficiencies. Studies explore how oral administration of Pyridoxine was associated with a change in circulating PLP (a key biomarker) levels when they were low. The evidence is largely based on observational and regulatory analyses, which contribute to understanding symptom patterns associated with functional imbalance during deficiency states.

Research in Drug-Related Deficiency and Prevention

Pyricontin was studied in the context of B6 deficiency associated with certain medications, notably Isoniazid (INH) therapy. Randomized controlled trials and observational cohorts examined the co-administration of Pyridoxine in patients receiving INH, monitoring outcomes related to the occurrence of peripheral neuropathy. Studies described patterns where the incidence of neuropathy varied between the group receiving B6 and the control group.

Studies in Pregnancy-Related Nausea and Vomiting

Pyridoxine HCl was evaluated in research exploring short-term symptom changes associated with Nausea and Vomiting of Pregnancy (NVP). Research, including randomized controlled trials, examined the use of B6 (often in combination with other agents) in pregnant women. Studies monitored patient-reported outcomes, and findings indicated that measurements of nausea severity varied between the groups studied, though evidence regarding vomiting frequency was mixed.

Areas of Uncertainty and Research Gaps

The research landscape contains limitations. Comparative evidence is lacking between the controlled-release Pyricontin formulation and standard, immediate-release B6 supplements across many applications. Follow-up durations were limited in studies that explored acute symptom patterns, and data for certain patient subgroups, such as older adults, remain insufficient.

Key Studies & References

  1. Label: PYRIDOXINE HCI injection, solution - DailyMed (FDA-regulated indications and use)
  2. What is the treatment for isoniazid-induced peripheral neuropathy? - Dr.Oracle AI (Clinical Guidelines and Prevention Strategies)

Frequently Asked Questions (FAQ)

Common questions about Pyricontin (FAQ)


Q: Is Pyricontin used to treat chronic conditions or short-term issues?

Official guidelines for Pyricontin describe its use for both short-term correction and long-term management of Vitamin B6 deficiency. This typically involves an initial intensive course to correct low levels, followed by a daily maintenance regimen. The purpose of the maintenance regimen is to help prevent the deficiency from recurring.

Q: How is Pyricontin different from the generic version, if there is one?

Pyricontin's active ingredient is Pyridoxine Hydrochloride, which is the generic form of Vitamin B6. The distinguishing feature of Pyricontin is its formulation as a Controlled-Release (CR) tablet. This specialized dosage form is designed to gradually release the ingredient over an extended duration, consistent with its controlled-release mechanism.

Q: What are the most common non-serious side effects associated with Pyricontin?

Official patient information indicates that the frequency of many side effects is not precisely known. However, regulatory sources mention potential effects associated with the active ingredient Pyridoxine, such as nausea, headache, drowsiness, and mild numbness or tingling. The most significant safety focus remains on the risk of nerve-related issues at very high doses.

Q: Does Pyricontin contain any opioids or controlled substances?

Pyricontin's active ingredient, Pyridoxine Hydrochloride, is classified by regulatory agencies as an essential water-soluble vitamin. It is affirmed as Generally Recognized As Safe ( GRAS) for use as a nutrient supplement in food. Official documentation does not list Pyricontin as an opioid or a controlled substance.

Q: Can Pyricontin cause a change in appetite or weight?

Official regulatory documents do not typically address weight change as a common or direct effect of Pyricontin. However, the active ingredient Pyridoxine has been associated with a loss of appetite in some reported cases.

Q: Is there a list of common foods or beverages to avoid while taking Pyricontin?

The regulatory labels primarily emphasize avoiding concurrent use with alcohol. This is due to the potential for additive depressant effects and the fact that alcohol can lower Vitamin B6 levels in the body. Official labels primarily focus on drug-drug and drug-alcohol interactions, and do not typically list specific dietary restrictions.

Q: Does Pyricontin interact negatively with common supplements like multivitamins?

Since Pyricontin is a Vitamin B6 supplement, official guidance notes the importance of considering total daily intake from all sources to ensure established upper limits are respected. Consult the drug's official label for its interactions with specific prescription drugs.

Q: Is it normal to feel a mild headache when first starting Pyricontin?

Headache is listed in regulatory documentation among the potential side effects associated with the active ingredient Pyridoxine. While the frequency of this event is often not precisely quantified, it is a known possible effect.

Q: Why do official documents emphasize the importance of using Pyricontin as prescribed?

Official documents stress adherence to prescribed use because of the link between high doses and the most serious adverse reactions. The most serious outcome, Severe Sensory Peripheral Neuropathy, is explicitly associated with the long-term administration of large daily doses, typically 200 mg or more per day.

Q: Can Pyricontin affect sleep patterns?

The active ingredient Pyridoxine has been linked in regulatory documents to somnolence, which is a state of drowsiness. Conversely, regulatory documents note that symptoms of a Vitamin B6 deficiency can sometimes include insomnia.

Q: Is there a high potential for dependence or withdrawal symptoms described for Pyricontin?

Regulatory documentation reports that symptoms of dependence have been observed in some adults. This was seen after prolonged periods of receiving specific high daily doses of Pyridoxine, followed by withdrawal. This is a topic of regulatory discussion within official documents.

Q: How does the mechanism of action of Pyricontin differ from other drugs in its class?

Pyricontin’s action is defined by enabling fundamental biochemical catalysis by supplying the precursor to the essential Pyridoxal 5'-Phosphate (PLP) coenzyme. In its class as a vitamin, its function is described as supporting existing metabolic machinery.

Q: Are there any non-drug interactions, like sunlight or certain activities, mentioned for Pyricontin?

While not a primary warning, some regulatory-related sources note a minor interaction between Pyridoxine and certain medications, such as Amiodarone, that may increase the risk of photosensitivity (sensitivity to sunlight). Beyond this, official labels do not list non-drug interactions like specific activities or environmental factors.

Q: Does taking Pyricontin require regular blood tests or monitoring?

Regulatory guidelines do not typically mandate routine blood tests for all users of Pyricontin. However, its potential to reduce the serum concentration of certain anticonvulsants, such as Phenytoin, may be a factor in specific patient management. Regulatory documents indicate that monitoring may be considered in specific patient scenarios.

Q: Is Pyricontin available in different strengths?

Yes, the active ingredient Pyridoxine Hydrochloride is commercially available in various tablet forms and strengths. This availability ranges from lower maintenance doses to higher therapeutic doses, including different forms of extended-release tablets.

Q: What is the primary way Pyricontin is eliminated from the body?

The body metabolizes the active ingredient into an inactive substance called 4-pyridoxic acid. According to official pharmacology sections, this substance is then primarily excreted from the body via the urine.

Q: Does Pyricontin carry a 'Black Box Warning' from the FDA or similar agency?

Official regulatory labels for Pyridoxine Hydrochloride, the active ingredient in Pyricontin, do not currently display a Black Box Warning. A Black Box Warning is the strongest safety warning issued by the FDA for a prescription drug.

Q: What are the guidelines regarding driving or operating heavy machinery while on Pyricontin?

The active ingredient in Pyricontin has a documented side effect of drowsiness, or somnolence. Official safety information notes that individuals should be aware of how the medication affects them before engaging in activities requiring complete mental alertness, such as driving or operating heavy machinery.

Q: What is the process for reporting a serious side effect related to Pyricontin?

Official regulatory labels advise patients to report suspected adverse reactions. This can be done by contacting the drug manufacturer directly, or by using the FDA’s official reporting system, known as MedWatch. The process described is consistent with FDA reporting guidelines; similar processes exist through local regulatory agencies in other jurisdictions.

Q: Why is it important to check the expiration date on Pyricontin packaging?

Official instructions specify that Pyricontin must be used by the expiration date printed on the package. This instruction is critical to ensuring the product maintains its stability and expected efficacy as defined by the manufacturer.

Q: Can people with a history of mental health issues use Pyricontin?

Pyricontin is essential for the synthesis of neurotransmitters, such as GABA, which modulate neuronal signaling. While there is no formal contraindication based on mental health history, symptoms of severe Vitamin B6 deficiency can sometimes include anxiety or confusion.

Q: How is Pyricontin manufactured or sourced?

The active ingredient in Pyricontin, Pyridoxine Hydrochloride, is a chemical compound. According to official regulatory information, this compound is prepared by chemical synthesis, meaning it is manufactured and not derived from a natural source.

Q: What steps are generally advised if a person experiences blurred vision while taking Pyricontin?

Blurred vision is not commonly listed as a direct side effect of Pyridoxine. However, official guidelines recommend seeking medical attention or contacting a health professional immediately if severe symptoms are experienced, including vision problems. This type of severe reaction should always be promptly addressed.

How should Pyricontin be stored and disposed of?

How to Store and Dispose of Pyricontin?

Pyricontin (Pyridoxine HCl) tablets must be stored at controlled room temperature, generally between 20 C and 25 C. It is mandatory to keep the medication from freezing and away from excess heat. The product must be stored in its original container and kept tightly closed to protect it from moisture and light, which ensures product stability. For safety, the medication must be kept securely out of the reach of children.

Disposal Requirements

Unused or expired Pyricontin should be disposed of via a drug take-back program. If a take-back program is unavailable, the product must be mixed with an undesirable substance (e.g., dirt or coffee grounds), sealed in a plastic bag, and then discarded in the household trash. The medication must not be flushed down the toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pyricontin found in:

A-Z Index: